
    
      Our objective is to understand the basic mechanisms that underpin substance dependence, and
      to develop efficacious treatments for individuals with comorbid cocaine and alcohol
      dependence.

      Participants in this study will be randomly assigned to receive either 300 mg per day of
      topiramate or placebo. In addition, participants will receive weekly cognitive behavioral
      therapy for 12 weeks.Follow-up visits will occur at 2 weeks and 1,2,, and 3 months following
      completion of treatment.
    
  